Beneficial effects of some donor-recipient HLA-DR mismatches on cadaveric graft survival: proposal for a new selection policy of recipients.
Vereerstraeten
P
P
Département Médico-Chirurgical de Néphrologie, Cliniques Universitaires de Bruxelles, Hôpital Erasme, Belgium.
Andrien
M
M
De Pauw
L
L
Dupont
E
E
Goldman
M
M
Abramowicz
D
D
Kinnaert
P
P
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D003524:Cyclosporins / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006684:HLA-DR Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology*; D011239:Prednisolone / Q000627:therapeutic use; D011446:Prospective Studies
D003524:Cyclosporins; D006684:HLA-DR Antigens; D011239:Prednisolone; D001379:Azathioprine